Helius Medical Technologies is trading at $2.68, up 5.49% in pre-market, with no clear company-specific catalyst identified.
- Available search results showed an earlier September 30 offering, but no new October 8 company announcement.
- Major U.S. indices are lower in the supplied market context, which does not clearly explain the stock’s gain.
- Premarket volume and activity level were unavailable in the provided price context.